WHO ICTRP trial
MAINTENANCE TREATMENT WITH ALEMTUZUMAB Campath AS AN ALTERNATIVE TO ALLOGENIC…
EUCTR2006-001164-24-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-001164-24-IT |
|---|---|
| Public title | MAINTENANCE TREATMENT WITH ALEMTUZUMAB Campath AS AN ALTERNATIVE TO ALLOGENIC TRANSPLANTATION IN PATIENTS WITHOUT COMPATIBLE DONOR IN PATIENTS WITH PERIPHERAL T CELL LYMPHOMA - ND |
| Scientific title | MAINTENANCE TREATMENT WITH ALEMTUZUMAB Campath AS AN ALTERNATIVE TO ALLOGENIC TRANSPLANTATION IN PATIENTS WITHOUT COMPATIBLE DONOR IN PATIENTS WITH PERIPHERAL T CELL LYMPHOMA - ND |
| Primary sponsor | G.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | patients with Perpheral T cell Lymphoma MedDRA version: 6.1 Level: HLGT Classification code 10025321 |
| Interventions | Trade Name: MABCAMPATH*IV 3F 3ML 10MG/ML Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Alemtuzumab Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- |
| Registration date | Mar 8, 2006 |
| Target size | 25 |
| Secondary IDs | PTCL01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: